Several other research analysts have also recently weighed in on the stock. Zacks Investment Research upgraded shares of Simulations Plus from a sell rating to a hold rating in a research note on Wednesday, March 20th. Taglich Brothers cut shares of Simulations Plus from a buy rating to a speculative buy rating in a research note on Wednesday, January 16th.
SLP stock traded up $0.86 on Thursday, hitting $23.19. The company had a trading volume of 37,747 shares, compared to its average volume of 50,297. The stock has a market capitalization of $406.17 million, a P/E ratio of 46.38 and a beta of -0.47. Simulations Plus has a 12-month low of $16.70 and a 12-month high of $23.95.
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Wednesday, April 24th were paid a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend was Tuesday, April 23rd. Simulations Plus’s dividend payout ratio (DPR) is 48.00%.
In other Simulations Plus news, Director David L. Ralph sold 3,000 shares of Simulations Plus stock in a transaction on Friday, April 12th. The shares were sold at an average price of $22.74, for a total value of $68,220.00. Following the sale, the director now directly owns 18,006 shares in the company, valued at approximately $409,456.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $20.64, for a total transaction of $381,840.00. Following the completion of the sale, the insider now owns 5,214,539 shares in the company, valued at $107,628,084.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 58,500 shares of company stock worth $1,241,120. 31.57% of the stock is owned by corporate insiders.
Several institutional investors have recently bought and sold shares of SLP. Wedge Capital Management L L P NC lifted its holdings in Simulations Plus by 16.5% during the first quarter. Wedge Capital Management L L P NC now owns 51,311 shares of the technology company’s stock valued at $1,083,000 after purchasing an additional 7,265 shares in the last quarter. BNP Paribas Arbitrage SA lifted its holdings in Simulations Plus by 59,875.0% during the first quarter. BNP Paribas Arbitrage SA now owns 2,399 shares of the technology company’s stock valued at $51,000 after purchasing an additional 2,395 shares in the last quarter. Redmond Asset Management LLC lifted its holdings in Simulations Plus by 1.8% during the first quarter. Redmond Asset Management LLC now owns 29,076 shares of the technology company’s stock valued at $614,000 after purchasing an additional 515 shares in the last quarter. Conestoga Capital Advisors LLC purchased a new position in Simulations Plus during the first quarter valued at $320,000. Finally, Geode Capital Management LLC lifted its holdings in Simulations Plus by 6.5% during the fourth quarter. Geode Capital Management LLC now owns 128,181 shares of the technology company’s stock valued at $2,550,000 after purchasing an additional 7,794 shares in the last quarter. Hedge funds and other institutional investors own 40.72% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.